Houston Medical Center Home
  • About our Organization
  • Commitment to Quality
  • Services
  • Health Information
  • Patient Information
  • Patient Financial Services
  • Careers & Benefits
  • Community Education
  • Physician Directory
  • Online Nursery
  • News
  • Contact Us
  • HHC Access

Health News Health Library Health Topics Healthy Living
Today's Headlines    Health Alerts    Health News Feature    Future of Medicine
Health Observances    Product Recalls
Illnesses & Conditions    Drug Guide    FDA Drug Approvals    Medical Tests    
Self-Help Resources
   Complementary Medicine    Medline Search
Allergies    Asthma    Back Pain    Cancer    Caregiver    Depression    Diabetes
Digestive Disorders    Heart Disease    Kidney Disease
Men's Health
   Pregnancy    Senior's Health    Stress    Stroke    Women's Health
Fitness   Nutrition   Mind & Body   Family & Home





Health Alerts
Health Alerts

Health Alerts
News that may affect you directly including health related warnings, recent discoveries and more.

Salmonella Saintpaul Outbreak

July 31, 2008

The U.S. Food and Drug Administration (FDA) is advising consumers that jalapeño and Serrano peppers grown in the United States are not connected with the current Salmonella St. Paul outbreak and consumers may feel free to eat them without concern of contamination. full story »

Baxter's Multiple-dose Vial Heparin

February 11, 2008

The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug. Serious reactions to the drug have included difficulty breathing, nausea, vomiting, excessive sweating, and rapidly falling blood pressure that can lead to life-threatening shock. full story »

Adverse Reactions Linked to Botox Use

February 8, 2008

The U.S. Food and Drug Administration today notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses. full story»



 
© 2007 Houston Healthcare Inc., All Rights Reserved. Design and Hosting: 3W Studios